Stocks moved in a narrow pre-bell session as investors digested a mix of corporate deal news, regulatory filings, and fresh analyst actions. Constellation Energy led the gain, jumping after Google disclosed large, long-term power supply agreements tied to new nuclear capacity. Elsewhere, Option Care Health surged on a reported advance in acquisition talks involving McKesson and a private equity firm, while several other companies rose on upgrades and deal-related developments.
Key takeaways
- Constellation Energy jumped on Google’s long-term power agreements tied to new nuclear output.
- Option Care Health surged after a Financial Times report said McKesson and Clayton Dubilier & Rice were in advanced talks for a deal valued at more than $5 billion.
- NeoGenomics rose following its succession plan and a third-quarter revenue update that beat consensus.
- Major analyst upgrades boosted several names, including Advanced Micro Devices, Procter & Gamble, and Corteva.
- Investor focus stayed on deal clarity and forward demand signals—from data center-linked power contracts to chip demand and farm-chemicals pricing.
What drove the biggest pre-bell winners
Google’s power agreements lifted Constellation Energy. Constellation Energy shares rose more than 6%, while Alphabet shares gained about 0.5%, after Google announced a major long-term power agreement with the company. The disclosure said Google will buy power tied to 890 megawatts of new nuclear capacity, alongside a separate 2,700-megawatt supply agreement. The contracts are expected to support more than $4.3 billion in new investment by Constellation.
Potential acquisition talks powered Option Care Health. Option Care Health shares jumped more than 20% after the Financial Times reported that McKesson and private equity firm Clayton Dubilier & Rice were in advanced talks to jointly acquire the infusion services provider. The reported transaction value was more than $5 billion. McKesson shares were up about 1.5% as investors processed the possibility of deal execution.
NeoGenomics combined leadership change with a revenue beat. NeoGenomics shares rose around 5% after the company announced a succession plan. Current President and COO Warren Stone is set to take the helm from Tony Cook in January 2027. The stock also received a lift from a preliminary third-quarter update: total revenue of $209 million, above the $205.9 million consensus estimate cited by FactSet.
Analyst upgrades and target changes supported other gains
Advanced Micro Devices found momentum after Citi’s target raise. AMD shares rose nearly 2% after Citi lifted its price target to $800, pointing to more than 26% upside from Monday’s close. Citi attributed the change to expectations for greater CPU demand, linking the outlook to Meta’s Muse AI agent. The bank said AMD would be the primary beneficiary of a “CPU renaissance.”
Procter & Gamble gained after an upgrade to outperform. Procter & Gamble shares rose about 1.2% following an Evercore ISI upgrade to outperform from in line. Evercore also increased its price target to $166 from $161, implying roughly 14% upside from Monday’s close. The move followed updated expectations reflected in the firm’s revised valuation.
Corteva rallied on a JPMorgan overweight call. Corteva shares gained nearly 3% after JPMorgan upgraded the stock to overweight from neutral. JPMorgan set a $19 price target, suggesting about 53% upside from Monday’s close, and said the company’s sharper focus on crop chemicals—along with improving agricultural commodity prices—could help support gains.
Regulatory filings added a smaller but clear signal
Berkshire Hathaway disclosed a Lennar stake change. In a regulatory filing, Berkshire Hathaway said it purchased about 2.4 million shares of Lennar. Lennar shares rose roughly 1.5%, while Berkshire’s stock was fractionally higher. For investors, the filing offered a tangible update to Berkshire’s exposure to homebuilder demand rather than a forward-looking guidance change.
Bigger picture: what investors will watch next
With pre-bell moves driven largely by contract visibility, reported deal progress, and near-term analyst revisions, investors are likely to keep pressure on companies that can translate announcements into operational momentum—whether that is power contracting that supports capital investment, acquisition discussions that move toward definitive terms, or revenue and product-demand signals that reinforce forward estimates. Upcoming earnings releases, additional corporate filings, and broader market inputs such as interest-rate expectations and economic data may further shape sentiment across these sectors.
